References
Atabay K, Yavuzer R, Latifoglu O, Ozmen S. Keratoderma hereditarium mutilans (Vohwinkel syndrome): an unsolved surgical mystery. Plast Reconstr Surg. 2001;108(5):1276–80.
Bassetto F, Tiengo C, Sferrazza R, et al. Vohwinkel syndrome: treatment of pseudo-ainhum. Int J Dermatol. 2010;49(1):79–82.
Chang Sing Pang A, Oranje A, Vuzevki V, et al. Succesful treatment of keratoderma hereditaria mutilans with an aromatic retinoid. Arch Dermatol. 1981;117:225–8.
Heller EH, Shiffman NJ. Synthetic retinoids in dermatology. Can Med Assoc J. 1985;132:1129–36.
Maestrini E, Korge BP, Ocana-Sierra J, et al. A missense mutation in connexin26, D66H, causes mutilating keratoderma with sensorineural deafness (Vohwinkel’s syndrome) in three unrelated families. Hum Mol Genet. 1999;8:1237.
Maestrini E, Monaco AP, McGrath JA, et al. A molecular defect in loricrin, .the major component of the cornified cell envelope, underlies Vohwinkel’s syndrome. Nat Genet. 1996;13:70.
Vohwinkel KH. Keratoderma hereditarium mutilans. Arch Dermtol Syph. 1929;158:354–64.
Wereide K. Mutilating palmoplantar keratoderma successfully treated with etretinate. Acta Derm Venereol. 1984;63:181.
White TW. Functional analysis of human Cx 26 mutations associated with deafness. Brain Res Rev. 2000;32(1):181–3.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Liebman, J.J., Liu, Y. Successful surgical management of keratoderma hereditaria mutilans. HAND 8, 102–104 (2013). https://doi.org/10.1007/s11552-012-9458-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11552-012-9458-5